Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Nature|November 2, 2022
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodentsRyuta Uraki, Peter J Halfmann, Shun Iida, et al.PNAS Nexus|January 20, 2025
An orally available P1'-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrierNobuyo Higashi-Kuwata, Haydar Bulut, Hironori Hayashi, et al.Viruses|December 16, 2020
Comparison of Rapid Antigen Tests for COVID-19Seiya Yamayoshi, Yuko Sakai-Tagawa, Michiko Koga, et al.Iscience|June 8, 2023
Potent neutralizing broad-spectrum antibody against SARS-CoV-2 generated from dual-antigen-specific B cells from convalescentsMasaru Takeshita, Hidehiro Fukuyama, Katsuhiko Kamada, et al.Nature Communications|March 24, 2023
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolatesRyuta Uraki, Shun Iida, Peter J Halfmann, et al.Iscience|November 21, 2022
Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal modelsMasaru Takeshita, Hidehiro Fukuyama, Katsuhiko Kamada, et al.Proceedings of the National Academy of Sciences of the United States of America|June 24, 2020
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure developmentMasaki Imai, Kiyoko Iwatsuki-Horimoto, Masato Hatta, et al.Research Square|March 2, 2022
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2Yoshihiro Kawaoka, Ryuta Uraki, Maki Kiso, et al.Nature|May 16, 2022
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2Ryuta Uraki, Maki Kiso, Shun Iida, et al.Proceedings of the National Academy of Sciences of the United States of America|June 18, 2021
Characterization of a new SARS-CoV-2 variant that emerged in BrazilMasaki Imai, Peter J Halfmann, Seiya Yamayoshi, et al.Pageof 3